Skip to main content
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. — Investor Relations & Filings

Ticker · BEAM ISIN · US07373V1052 US Manufacturing
Open in API
Filings indexed 457 across all filing types
Latest filing 2020-09-28 Regulatory Filings
Country US United States of America
Listing US BEAM

About Beam Therapeutics Inc.

https://beamtx.com/

Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. This approach is designed to make precise, single-letter edits to the genome without causing double-stranded breaks in the DNA, aiming to overcome the limitations of traditional gene editing methods. The company's pipeline focuses on creating potential life-long cures for genetic disorders, including sickle cell disease, beta-thalassemia, and alpha-1 antitrypsin deficiency. Beam Therapeutics is also advancing a suite of delivery technologies, such as electroporation, nonviral, and viral modalities, to deliver its base editors to target cells.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings Classification · 100% confidence The document is a letter from Beam Therapeutics Inc. to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-1. It is a correspondence related to a securities registration process, specifically a request for acceleration under Rule 461 of the Securities Act. The document is short (1313 characters) and does not contain financial statements, management discussion, or detailed financial data. It is not a report itself but an official regulatory filing related to the registration process. Therefore, it fits best under Regulatory Filings (RNS).
2020-09-28 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC). It is a detailed registration statement for a public offering of common stock by Beam Therapeutics Inc. The text includes the SEC header, registration number, company details, offering details, risk factors, use of proceeds, underwriting information, and other disclosures typical of an S-1 filing. This type of document is used to register securities for an initial public offering (IPO) or other public offerings and is not an annual report, earnings release, or any other report type listed. The S-1 registration statement is a capital markets filing related to financing activities and capital raising. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the full filing, not just an announcement or summary.
2020-09-28 English
Regulatory Filings 2020
Regulatory Filings
2020-09-23 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-22 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for registering securities for public offering. It includes detailed information about the company, the offering, risk factors, use of proceeds, underwriting, and other disclosures typical of an IPO or public offering registration. It is not an annual report, earnings release, or any other financial report type. It is a capital markets filing related to fundraising and securities registration under the Securities Act of 1933. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual filing, not just an announcement. Hence, the classification is CAP with high confidence.
2020-09-18 English
Regulatory Filings 2020
Regulatory Filings Classification · 95% confidence The document is a confidential submission letter to the SEC for a draft Registration Statement on Form S-1 related to a proposed offering of common stock by Beam Therapeutics Inc. It references the IPO Registration Statement and the confidential submission process under SEC rules. This is not the actual registration statement or offering document itself, but a cover letter for the draft submission. The document length is short (1971 characters) and it is clearly an announcement/cover letter for a filing, not a full financial or regulatory report. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements and filings that do not fit other categories.
2020-09-18 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.